International association and business events executive and world traveler. Opinions are my own. Retweets do not imply endorsement.
Miami / Vienna / DC / Brussels
Joined April 2009
- Tweets2.9K
- Following567
- Followers1.4K
- Likes12.1K
Thomas Reiser retweeted
🎉 Today is #WorldThrombosisDay!
Your voice matters! Take the World Thrombosis Day Pledge to show your support for better prevention, diagnosis, and treatment of thrombosis.
👉 Sign today and comment below to tell us from what country you are signing: bit.ly/3WANzgI
Thomas Reiser retweeted
⏰ Tomorrow is #WorldThrombosisDay!
✍️ One simple way to get involved: Sign the World Thrombosis Day Pledge! Show your commitment to spreading awareness and preventing thrombosis worldwide.
🔗 Take the pledge now: bit.ly/3WANzgI
Thomas Reiser retweeted
The silent threat of blood clots doesn't discriminate. While patients with cancer face up to a 5x higher risk, anyone can develop a serious clot. The life-saving defense we all share? Simply moving our bodies.
Sometimes the most powerful medicine isn't prescribed—it's the movement we choose every day.
✨ LET’S GET PHYSICAL: Share your favorite way to stay active in the comments—whether you're in cancer treatment or simply caring for your health.
#CancerCare #ActiveAgainstClots #MovementIsMedicine #EveryBodyMatters #BloodClotPrevention #WTDay25 #LEOPharma
Thomas Reiser retweeted
📣#ISTH2025 Congress abstracts now published in RPTH! Take a few moments to review the groundbreaking science that is being shared in Washington, D.C.
Click here to view: rpthjournal.org/issue/S2475-…
Thomas Reiser retweeted
#ISTH2025 is here. The opening session starts at 500 in Ballroom A-C with a message from @isth president @PantepAng followed by awards followed by me with an opening and fun welcome (you won’t want miss it) and then our Opening Plenary.
Thomas Reiser retweeted
WEBINAR:
Join us for a deep dive into the challenges of studying complex populations — with insights from the pilot PARTUM trial!
📅 June 4 | 14:00 UTC
📷 Featuring: @leslieskeith
📷mailchi.mp/6493ad2b0b59/glob……
#Thrombosis #VTE #ClinicalTrials #Research #PARTUM
Thomas Reiser retweeted
Our editorial on #hemophilia treatments and the paradox of choice is now available in the journal Research and Practice in Thrombosis and Haemostasis. @RPTHjournal
Thomas Reiser retweeted
📢🚨SCAM NOTICE: If you receive any communications regarding hotel bookings or special rates from solicitors, agencies, or a non – ISTH account, please exercise caution, and do not provide any information.
As a reminder all official email addresses from the ISTH end with @isth.org. If you have doubts or concerns about the legitimacy of an email regarding hotels, please reach out to us at [email protected] or [email protected]
Thomas Reiser retweeted
📢The SSC Subcommittee on Platelet Immunology is asking for participants for their survey on heavy menstrual bleeding in ITP, looking at common practices and knowledge. Take the survey here: bit.ly/3F3HxzP
Thomas Reiser retweeted
🔔Early Bird Alert! Time is ticking! The #ISTH2025 early registration deadline is coming up on April 22. Don’t miss your chance to lock in the best rates for this must-attend event on bleeding & clotting disorders.
💰Click here to secure the LOWEST rates: isth2025.org/register
Thomas Reiser retweeted
The ISTH invites you to share your insights on its draft recommendations for treating TTP. Whether you're a clinician, researcher, health professional, policymaker, industry representative, patient, or caregiver, your input is invaluable: bit.ly/4ipu3wz
Thomas Reiser retweeted
🚨New Research Alert! ISTH members authored a major new study on acute PE in children and adolescents, published in @TheLancet Respiratory Medicine! This study sheds critical light on the incidence and outcomes of PE in young patients.
Learn more here: isth.org/news/news.asp?id=69…
Thomas Reiser retweeted
Join us for the upcoming @isth webinar on Jan. 29 20:00 UTC/15:00 EST.
Drs. A. Kiskaddon & D. Swan will discuss clin. & pharmac. perspectives for #anticoagulation in patients w/chronic #kidney disease (#CKD).
👉 bit.ly/407maEv
@ISNkidneycare @ERAkidney @ASNKidney
Thomas Reiser retweeted
Exciting News! The ISTH SSC has awarded new grants to support innovative projects in thrombosis and hemostasis research. These grants aim to advance scientific discovery and improve patient care worldwide. 🌍
📚 Learn more about the groundbreaking initiatives here: bit.ly/3DKA7AS
Thomas Reiser retweeted
Dive into the inspiring story of Dr. Charithani Bhagya Keragala, an ISTH Training Fellow making impactful strides in thrombosis and hemostasis research. 💡
Learn about her journey, her research focus, and how the ISTH Training Fellowship is empowering her to advance science and improve patient care.
🔗 Read her story here: isth.org/news/689100/Meet-th…
Thomas Reiser retweeted
💙 Be a Key Partner in the 2025 World Thrombosis Day Campaign! 💙
Why support the 2025 WTD campaign?
✨ Gain global exposure
✨ Showcase your brand
✨ Connect with influential healthcare professionals
Together, we can make 2025 a turning point in the fight against thrombosis
Thomas Reiser retweeted
Another great #JTHinClinic Review!
Dedicated strategies are needed to address emergency room clinician barriers to utilizing guideline-recommended outpatient management of low-risk pulmonary embolism. #PE #thrombosis
@HenryBHanMD
@Klinelab
@CFGreineder
@GBarnesMD
Read more at jthjournal.org/article/S1538…
Thomas Reiser retweeted
If you plan to chat about #WorldThrombosisDay on/around October 13, don't forget to use our official hashtag: #WTDay24
Thomas Reiser retweeted
Hi ISTH X community. Please share this for me: We've lost access to our ISTH X/Twitter account, and we're working to recover it. If you receive any contact or DMs from ISTH, please do not engage. I have not received any reports of this happening yet, but I wanted to alert you.